CLNN
Clene Inc.$5.98-0.08 (-1.32%)Prev Close$6.06·MCap$51.1M·P/E—·Vol14.8K·Yield—
▲
Buys (12M)
1
$216.7K
▼
Sells (12M)
19
$4.53M
◆
Net Activity
Net Seller
$4.32M
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Clene Inc. (CLNN) has been dominated by selling, with 1 insider purchase totaling $216.7K and 19 insider sales totaling $4.53M. The most recent insider transaction was by Ugwumba Chidozie (10 percent owner), who sold $403.1K worth of shares on Apr 22, 2026. Clene Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $51.1M.
CLNN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 65,663 | $6.14 | $403.1K0.7% OS | 358,411 |
| Apr 17, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 39,162 | $6.43 | $251.9K | 395,517 |
| Apr 6, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 24,925 | $4.81 | $119.9K | 401,891 |
| Apr 1, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 4,278 | $4.97 | $21.3K | 426,816 |
| Mar 31, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 100,997 | $4.89 | $494.0K1.0% OS | 514,621 |
| Mar 26, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 17,909 | $5.56 | $99.5K | 544,508 |
| Feb 3, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 5,559 | $4.10 | $22.8K | 0 |
| Jan 29, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 24,770 | $4.23 | $104.9K | 0 |
| Jan 26, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 19,274 | $4.98 | $96.0K | 0 |
| Jan 22, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 18,221 | $5.30 | $96.7K | 0 |
| Jan 16, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 32,474 | $4.97 | $161.5K | 0 |
| Jan 13, 2026 | MATLIN DAVID J | Director | Buy | 33,333 | $6.50 | $216.7K | 0 |
| Jan 13, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 58,289 | $5.01 | $292.2K0.6% OS | 0 |
| Jan 8, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 44,975 | $5.70 | $256.2K | 0 |
| Jan 5, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 12,918 | $6.04 | $78.0K | 0 |
| Dec 31, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 17,110 | $5.79 | $99.1K | 0 |
| Dec 29, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 12,234 | $5.98 | $73.1K | 0 |
| Dec 23, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 436,029 | $0.17 | $73.8K4.4% OS | 0 |
| Dec 19, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 9,949 | $6.49 | $64.6K | 0 |
| Dec 3, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 257,795 | $6.69 | $1.73M2.6% OS | 0 |
| Sep 30, 2024 | Etherington Robert Dee | Chief Executive Officer | Buy | 10,000 | $4.75 | $47.5K | 0 |
| Sep 30, 2024 | MATLIN DAVID J | Director | Buy | 92,307 | $4.75 | $438.5K0.9% OS | 0 |
| Sep 30, 2024 | Mortenson Mark | Chief Science Officer | Buy | 20,512 | $4.75 | $97.4K | 0 |
| Nov 10, 2023 | MATLIN DAVID J | Director | Buy | 250,002 | $0.41 | $102.5K2.5% OS | 0 |
| Jun 26, 2023 | Etherington Robert Dee | Chief Executive Officer | Buy | 25,000 | $0.81 | $20.3K | 0 |
| Jun 26, 2023 | Stevens John Henry | Director | Buy | 316,455 | $0.80 | $253.2K3.2% OS | 0 |
| Jun 16, 2023 | Gay Jonathon | Director | Buy | 105,625 | $0.80 | $84.5K1.1% OS | 0 |
| Jun 16, 2023 | MATLIN DAVID J | Director | Buy | 1,500,000 | $0.80 | $1.20M15.0% OS | 0 |
| Jun 16, 2023 | Mosca Alison | Director | Buy | 2,394,375 | $0.80 | $1.92M23.9% OS | 0 |
| Jun 16, 2023 | Ugwumba Chidozie | 10% Owner | Buy | 7,500,000 | $0.80 | $6.00M75.0% OS | 0 |
| Nov 2, 2022 | Gay Jonathon | Director | Buy | 990,099 | $1.01 | $1.00M9.9% OS | 0 |
| Nov 2, 2022 | MATLIN DAVID J | Director | Buy | 2,871,287 | $1.01 | $2.90M28.7% OS | 0 |
| Nov 2, 2022 | Mosca Alison | Director | Buy | 792,079 | $1.01 | $800.0K7.9% OS | 0 |
| Nov 2, 2022 | Stevens John Henry | Director | Buy | 148,515 | $1.01 | $150.0K1.5% OS | 0 |
| Aug 17, 2022 | Stevens John Henry | Director | Buy | 47,662 | $3.85 | $183.5K | 0 |
| Jul 18, 2022 | Etherington Robert Dee | Chief Executive Officer | Sell | 23,483 | $4.72 | $110.8K | 0 |
| Jun 16, 2022 | MATLIN DAVID J | Director | Buy | 149,610 | $2.50 | $374.8K1.5% OS | 0 |
| Jun 16, 2022 | Mortenson Mark | Chief Science Officer | Sell | 20,247 | $2.47 | $50.0K | 0 |
| Jun 15, 2022 | Mosca Alison | Director | Buy | 5,000 | $2.62 | $13.1K | 0 |
| Jun 14, 2022 | MATLIN DAVID J | Director | Buy | 96,011 | $2.66 | $255.4K1.0% OS | 0 |
| Jun 13, 2022 | MATLIN DAVID J | Director | Buy | 55,000 | $3.06 | $168.3K0.6% OS | 0 |
| Jun 3, 2022 | MATLIN DAVID J | Director | Buy | 60,670 | $2.55 | $154.8K0.6% OS | 0 |
| May 27, 2022 | MATLIN DAVID J | Director | Buy | 35,000 | $2.27 | $79.5K | 0 |
| May 16, 2022 | Gay Jonathon | Director | Buy | 10,000 | $2.08 | $20.8K | 0 |
| May 16, 2022 | Glanzman Robert | Chief Medical Officer | Sell | 4,717 | $2.03 | $9.6K | 0 |
| May 16, 2022 | MATLIN DAVID J | Director | Buy | 181,818 | $2.20 | $400.0K1.8% OS | 0 |
| Apr 20, 2022 | MATLIN DAVID J | Director | Buy | 132,891 | $3.01 | $400.0K1.3% OS | 0 |
| Mar 28, 2022 | MATLIN DAVID J | Director | Buy | 18,648 | $3.16 | $58.9K | 0 |
| Mar 23, 2022 | MATLIN DAVID J | Director | Buy | 40,000 | $2.97 | $118.6K | 0 |
| Mar 18, 2022 | MATLIN DAVID J | Director | Buy | 55,000 | $2.86 | $157.3K0.6% OS | 0 |
Showing 1–50 of 58
1 / 2
CLNN Insider Buying Activity
The following table shows recent insider purchases of Clene Inc. (CLNN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | MATLIN DAVID J | Director | Buy | 33,333 | $6.50 | $216.7K | 0 |
| Sep 30, 2024 | Etherington Robert Dee | Chief Executive Officer | Buy | 10,000 | $4.75 | $47.5K | 0 |
| Sep 30, 2024 | MATLIN DAVID J | Director | Buy | 92,307 | $4.75 | $438.5K0.9% OS | 0 |
| Sep 30, 2024 | Mortenson Mark | Chief Science Officer | Buy | 20,512 | $4.75 | $97.4K | 0 |
| Nov 10, 2023 | MATLIN DAVID J | Director | Buy | 250,002 | $0.41 | $102.5K2.5% OS | 0 |
| Jun 26, 2023 | Etherington Robert Dee | Chief Executive Officer | Buy | 25,000 | $0.81 | $20.3K | 0 |
| Jun 26, 2023 | Stevens John Henry | Director | Buy | 316,455 | $0.80 | $253.2K3.2% OS | 0 |
| Jun 16, 2023 | Gay Jonathon | Director | Buy | 105,625 | $0.80 | $84.5K1.1% OS | 0 |
| Jun 16, 2023 | MATLIN DAVID J | Director | Buy | 1,500,000 | $0.80 | $1.20M15.0% OS | 0 |
| Jun 16, 2023 | Mosca Alison | Director | Buy | 2,394,375 | $0.80 | $1.92M23.9% OS | 0 |
| Jun 16, 2023 | Ugwumba Chidozie | 10% Owner | Buy | 7,500,000 | $0.80 | $6.00M75.0% OS | 0 |
| Nov 2, 2022 | Gay Jonathon | Director | Buy | 990,099 | $1.01 | $1.00M9.9% OS | 0 |
| Nov 2, 2022 | MATLIN DAVID J | Director | Buy | 2,871,287 | $1.01 | $2.90M28.7% OS | 0 |
| Nov 2, 2022 | Mosca Alison | Director | Buy | 792,079 | $1.01 | $800.0K7.9% OS | 0 |
| Nov 2, 2022 | Stevens John Henry | Director | Buy | 148,515 | $1.01 | $150.0K1.5% OS | 0 |
| Aug 17, 2022 | Stevens John Henry | Director | Buy | 47,662 | $3.85 | $183.5K | 0 |
| Jun 16, 2022 | MATLIN DAVID J | Director | Buy | 149,610 | $2.50 | $374.8K1.5% OS | 0 |
| Jun 15, 2022 | Mosca Alison | Director | Buy | 5,000 | $2.62 | $13.1K | 0 |
| Jun 14, 2022 | MATLIN DAVID J | Director | Buy | 96,011 | $2.66 | $255.4K1.0% OS | 0 |
| Jun 13, 2022 | MATLIN DAVID J | Director | Buy | 55,000 | $3.06 | $168.3K0.6% OS | 0 |
| Jun 3, 2022 | MATLIN DAVID J | Director | Buy | 60,670 | $2.55 | $154.8K0.6% OS | 0 |
| May 27, 2022 | MATLIN DAVID J | Director | Buy | 35,000 | $2.27 | $79.5K | 0 |
| May 16, 2022 | Gay Jonathon | Director | Buy | 10,000 | $2.08 | $20.8K | 0 |
| May 16, 2022 | MATLIN DAVID J | Director | Buy | 181,818 | $2.20 | $400.0K1.8% OS | 0 |
| Apr 20, 2022 | MATLIN DAVID J | Director | Buy | 132,891 | $3.01 | $400.0K1.3% OS | 0 |
| Mar 28, 2022 | MATLIN DAVID J | Director | Buy | 18,648 | $3.16 | $58.9K | 0 |
| Mar 23, 2022 | MATLIN DAVID J | Director | Buy | 40,000 | $2.97 | $118.6K | 0 |
| Mar 18, 2022 | MATLIN DAVID J | Director | Buy | 55,000 | $2.86 | $157.3K0.6% OS | 0 |
CLNN Insider Selling Activity
The following table shows recent insider sales of Clene Inc. (CLNN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 65,663 | $6.14 | $403.1K0.7% OS | 358,411 |
| Apr 17, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 39,162 | $6.43 | $251.9K | 395,517 |
| Apr 6, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 24,925 | $4.81 | $119.9K | 401,891 |
| Apr 1, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 4,278 | $4.97 | $21.3K | 426,816 |
| Mar 31, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 100,997 | $4.89 | $494.0K1.0% OS | 514,621 |
| Mar 26, 2026 | Ugwumba Chidozie | 10 percent owner | Sell | 17,909 | $5.56 | $99.5K | 544,508 |
| Feb 3, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 5,559 | $4.10 | $22.8K | 0 |
| Jan 29, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 24,770 | $4.23 | $104.9K | 0 |
| Jan 26, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 19,274 | $4.98 | $96.0K | 0 |
| Jan 22, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 18,221 | $5.30 | $96.7K | 0 |
| Jan 16, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 32,474 | $4.97 | $161.5K | 0 |
| Jan 13, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 58,289 | $5.01 | $292.2K0.6% OS | 0 |
| Jan 8, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 44,975 | $5.70 | $256.2K | 0 |
| Jan 5, 2026 | Ugwumba Chidozie | 10% Owner | Sell | 12,918 | $6.04 | $78.0K | 0 |
| Dec 31, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 17,110 | $5.79 | $99.1K | 0 |
| Dec 29, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 12,234 | $5.98 | $73.1K | 0 |
| Dec 23, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 436,029 | $0.17 | $73.8K4.4% OS | 0 |
| Dec 19, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 9,949 | $6.49 | $64.6K | 0 |
| Dec 3, 2025 | Ugwumba Chidozie | 10% Owner | Sell | 257,795 | $6.69 | $1.73M2.6% OS | 0 |
| Jul 18, 2022 | Etherington Robert Dee | Chief Executive Officer | Sell | 23,483 | $4.72 | $110.8K | 0 |
| Jun 16, 2022 | Mortenson Mark | Chief Science Officer | Sell | 20,247 | $2.47 | $50.0K | 0 |
| May 16, 2022 | Glanzman Robert | Chief Medical Officer | Sell | 4,717 | $2.03 | $9.6K | 0 |
CLNN Insiders
Similar Stocks to CLNN
VRTX
Vertex Pharmaceuticals Incorporated
$428.36+0.55%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$739.29-0.68%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$305.75-0.85%
$41.24B
INSM
Insmed Incorporated
$133.16-2.19%
$30.79B
RVMD
Revolution Medicines, Inc.
$145.59+10.58%
$29.51B
UTHR
United Therapeutics Corporation
$566.37-0.28%
$25.13B
MRNA
Moderna, Inc.
$46.93-3.64%
$21.42B
RPRX
Royalty Pharma plc
$49.63-0.02%
$21.20B